These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Emerging relations between infectious diseases and coronary artery disease and atherosclerosis. Fong IW CMAJ; 2000 Jul; 163(1):49-56. PubMed ID: 10920732 [TBL] [Abstract][Full Text] [Related]
45. Hypersensitivity to endotoxin and mechanisms of host-response. Galanos C; Freudenberg MA; Matsuura M; Coumbos A Prog Clin Biol Res; 1988; 272():295-308. PubMed ID: 3393569 [TBL] [Abstract][Full Text] [Related]
46. Infections and their role in atherosclerotic vascular disease. Fong IW J Am Dent Assoc; 2002 Jun; 133 Suppl():7S-13S. PubMed ID: 12085725 [TBL] [Abstract][Full Text] [Related]
47. [Serum neopterin levels after extensive burns and their relationship to endotoxemia and sepsis]. Yao Y; Yu Y; Sheng Z Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1997 Sep; 13(5):357-60. PubMed ID: 10452047 [TBL] [Abstract][Full Text] [Related]
48. Periodontal infections and cardiovascular disease--how strong is the association? Armitage GC Oral Dis; 2000 Nov; 6(6):335-50. PubMed ID: 11355266 [TBL] [Abstract][Full Text] [Related]
49. Infections, atherosclerosis, and coronary heart disease. Famularo G; Trinchieri V; Santini G; De Simone C Ann Ital Med Int; 2000; 15(2):144-55. PubMed ID: 10920505 [TBL] [Abstract][Full Text] [Related]
50. Complement and atherogenesis: the unknown connection. Bhakdi S Ann Med; 1998 Dec; 30(6):503-7. PubMed ID: 9920350 [TBL] [Abstract][Full Text] [Related]
51. Influence of Helicobacter pylori infection during atherogenesis in vivo in mice. Mach F; Sukhova GK; Michetti M; Libby P; Michetti P Circ Res; 2002 Jan; 90(1):E1-4. PubMed ID: 11786527 [TBL] [Abstract][Full Text] [Related]
52. The role of endotoxin in infection: Helicobacter pylori and Campylobacter jejuni. Moran AP Subcell Biochem; 2010; 53():209-40. PubMed ID: 20593269 [TBL] [Abstract][Full Text] [Related]
53. Acute inflammation and microthrombosis induced by endotoxin, interleukin-1, and tumor necrosis factor and their implication in gram-negative infection. Cybulsky MI; Chan MK; Movat HZ Lab Invest; 1988 Apr; 58(4):365-78. PubMed ID: 3282123 [No Abstract] [Full Text] [Related]
54. Recruitment of Chlamydia pneumoniae-infected macrophages to the carotid artery wall in noninfected, nonatherosclerotic mice. May AE; Redecke V; Grüner S; Schmidt R; Massberg S; Miethke T; Ryba B; Prazeres da Costa C; Schömig A; Neumann FJ Arterioscler Thromb Vasc Biol; 2003 May; 23(5):789-94. PubMed ID: 12663369 [TBL] [Abstract][Full Text] [Related]
55. Secondary prevention of coronary artery disease with antimicrobials: current status and future directions. Muhlestein JB Am J Cardiovasc Drugs; 2002; 2(2):107-18. PubMed ID: 14727986 [TBL] [Abstract][Full Text] [Related]
56. Chlamydia, inflammation, and atherogenesis. Rosenfeld ME; Blessing E; Lin TM; Moazed TC; Campbell LA; Kuo C J Infect Dis; 2000 Jun; 181 Suppl 3():S492-7. PubMed ID: 10839746 [TBL] [Abstract][Full Text] [Related]
57. The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. Hu H; Pierce GN; Zhong G J Clin Invest; 1999 Mar; 103(5):747-53. PubMed ID: 10074493 [TBL] [Abstract][Full Text] [Related]
59. Chlamydia pneumoniae and atherosclerosis: does the evidence support a causal or contributory role? Mahony JB; Coombes BK FEMS Microbiol Lett; 2001 Apr; 197(1):1-9. PubMed ID: 11287138 [TBL] [Abstract][Full Text] [Related]
60. Macrophage migration inhibitory factor (MIF) modulates innate immune responses induced by endotoxin and Gram-negative bacteria. Roger T; Glauser MP; Calandra T J Endotoxin Res; 2001; 7(6):456-60. PubMed ID: 11753217 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]